RhumbLine Advisers’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Buy |
+24,958
| New | +$1.22M | ﹤0.01% | 2152 |
|
|
2021
Q2 | – | Sell |
-1,392
| Closed | -$74K | – | 3006 |
|
|
2021
Q1 | $74K | Sell |
1,392
-225
| -14% | -$12K | ﹤0.01% | 2960 |
|
|
2020
Q4 | $65K | Buy |
1,617
+439
| +37% | +$17.6K | ﹤0.01% | 3006 |
|
|
2020
Q3 | $67K | Sell |
1,178
-219
| -16% | -$12.5K | ﹤0.01% | 2934 |
|
|
2020
Q2 | $103K | Buy |
+1,397
| New | +$103K | ﹤0.01% | 2962 |
|
|
2017
Q2 | – | Sell |
-695
| Closed | -$108K | – | 2928 |
|
|
2017
Q1 | $108K | Buy |
695
+31
| +5% | +$4.82K | ﹤0.01% | 2771 |
|
|
2016
Q4 | $138K | Sell |
664
-162
| -20% | -$33.7K | ﹤0.01% | 2759 |
|
|
2016
Q3 | $189K | Buy |
826
+122
| +17% | +$27.9K | ﹤0.01% | 2697 |
|
|
2016
Q2 | $145K | Buy |
+704
| New | +$145K | ﹤0.01% | 2839 |
|